Navigation Links
Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah
Date:7/16/2008

LA JOLLA, Calif., July 16 /PRNewswire-FirstCall/ -- Immunosyn Corporation (OTC Bulletin Board: IMYN) announced today that the distribution of SF-1019 in the State of Utah is anticipated to begin shortly through Renewed Hope Clinic in Beaver, Utah.

Immunosyn is negotiating an exclusive license agreement for the administration and distribution of SF-1019 in the State of Utah with Utah Biopharmaceutical Laboratories, LLC.

Immunosyn has been advised by Argyll Biotechnologies, LLC, the licensor of SF-1019, Immunosyn's strategic partner and its largest shareholder, that Argyll Biotech is negotiating a three-party agreement with its current domestic third party manufacturer and Utah Biopharmaceutical Laboratories for Utah Biopharmaceuticals Laboratories to be a third party manufacturer of SF-1019 in the State of Utah. Argyll Biotech has worked for several years on developing the manufacturing processes, protocols, safety procedures and guidelines for SF-1019. Immunosyn, together with Argyll Biotech and Utah Biopharmaceutical Laboratories, is working to finalize Distribution Management and Information Component Systems that will be implemented to define protocols to assure patient safety and regulatory compliance in Utah prior to treatment commencing.

The combination of the proposed license and manufacturing agreements will allow for SF-1019 to be administered in the State of Utah exclusively by Utah Biopharmaceutical Laboratories through Renewed Hope Clinic which is located in Beaver, Utah.

"I am excited to have the ability to treat patients with this therapeutic modality, which is not yet available elsewhere in the U.S. My review of the scientific background, preclinical testing, initial safety evaluations and studies performed under compassionate waivers, coupled with the therapeutic benefits I have witnessed, give me confidence in the benefit my patients will receive from SF-1019 treatment," said Mitchell J. Melling, MD, Manager of Uta
'/>"/>

SOURCE Immunosyn Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Immunosyn Corporation Names Stephen Ferrone as CEO
2. Immunosyn Corporation to Begin Trading
3. Equity Research Firm Issued Unauthorized Report and Press Release on Immunosyn Corporation Today
4. Immunosyn Announces the Successful Completion of First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
5. Douglas A. McClain, Jr. Resumes CFO Duties at Immunosyn
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
8. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
9. HEI, Inc. Announces Sale of RFID Division Assets
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ich., Dec. 1 First Merc...Mercury" or the "Company") announced today that on... a quarterly cash dividend of $0.025 per share, to...rd at the close of business on December 15, 2009. ... ,, First Mercury Financial Corporation provid...
(Date:12/1/2009)...tral and South America, study finds , , ...nt of intensive care unit patients worldwide suffe...n the hospital, a new study finds. , Researcher...2007) on 13,796 patients, aged 18 and older, in 1,...nt of patients were classified as infected and 71 ...
(Date:12/1/2009)... affirming, isolating behaviors jump from friend ... News) -- A new study suggests that lonely people ...feel lonely, too. , "Loneliness can spread from... of separation," said James H. Fowler, co-author o... Journal of Personality and Social Psychology , a...
(Date:12/1/2009)... 1, 2009) Wistar Institute researchers and collab...w York University have identified immune system ma... tumors in people at high risk for developing lung... in Cancer Research , a journal of the American A...mple blood test to detect lung cancer in its earli...
(Date:12/1/2009)... Practitioners of any medical, legal or business r... a sigh of relief this week with the release of ,D... released over the holiday weekend, allows anyone ...s to do so quickly and seamlessly using just the i...) December 1, 2009 -- The iPhone App, released by ...
Breaking Medicine News(10 mins):Health News:Half of ICU Patients Suffer From Infections 2Health News:Loneliness May Be Catching 2Health News:Loneliness May Be Catching 3Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 3Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2
...for Industry Ashwini Kumar speaking at a national ...lised', // today urged the corporate sector in Ind...ob opportunities to disabled people. It is only th...s unflinching but industry experts should draw up ...
...s Prozac, Paxil and Zoloft, prescribed to the elde...ughts in its recipients//, especially in the first...edication to treat depression. Earlier studie... or SSRIs. But there has not been much research on...
...o do with seasons? An exhaustive study on suicide ...onounced with those born in spring or summer//. ...t occurred between 1979 and 2001 in England and Wa.... This tendency was more pronounced amongst women,...
...ion breast cancer survivors have been found to be ...dvances have helped in the longer management of t... that about a third of these long-term survivors d...les found that not all survivors suffer from fatig...
...ncluded that several young men treat their erectio...ithout a doctors prescription. // These results we...ged 18-25 at three Chicago universities. The r...iatric Academic Societies’ annual meeting. It reve...
...nducted on more than 57,000 children found that gr.../ like being poor or having a single mother who is...of becoming sick, immaterial of race or health ins...en, but this study is the first to show that incre...
Other Medicine News:Health News:Minister Of State For Industry Urges Corporate Sectors To Help India's Disabled Population 2Health News:Breast Cancer Survivors Growing in Numbers 2Health News:Young Men Treating Erection Problems without Doctors Prescription 2Health News:A New Study Shows Social Well Being Plays An Important Part In Childs Health 2Health News:A New Study Shows Social Well Being Plays An Important Part In Childs Health 3
(Date:12/1/2009)..., BOTHELL, Wash., Dec. 1 ...hat on November 20, 2009 it licensed to Chrono Nut...facture and sell four extended release dietary sup...delivery platform. In addition, SCOLR granted Chr...ducts in the United States on a nonexclusive basis...
(Date:12/1/2009)...LEN BURNIE, Md., Dec. 1 Sleep Solu...rvice provider for home testing and evaluation of ... named Richard Hassett, M.D., as its chief executi...f Matria Healthcare, during its growth from a $250...llion industry leader in total population health, ...
(Date:12/1/2009)... , TAI,AN, China, Dec. 1 /PRNewswire-Asia...Bulletin Board: CBPO) (Nasdaq: CBPO ) ("China Bio...ma-based biopharmaceutical companies in,China, tod...l to list its,common stock on the NASDAQ Global Ma... to begin trading on the NASDAQ on,Wednesday, Dece...
Breaking Medicine Technology:SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 2Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 3China Biologic Products Approved to List on NASDAQ 2China Biologic Products Approved to List on NASDAQ 3US Oncology Inc Announces 24465 Million Senior Secured Notes Offering 47879 1US Oncology Inc Announces 24465 Million Senior Secured Notes Offering 47879 2DATATRAK Announces Receipt of NASDAQ Panel Decision to Delist Common Shares 47877 1DATATRAK Announces Receipt of NASDAQ Panel Decision to Delist Common Shares 47877 2DATATRAK Announces Receipt of NASDAQ Panel Decision to Delist Common Shares 47877 3DATATRAK Announces Receipt of NASDAQ Panel Decision to Delist Common Shares 47877 4Xceed Meets HTX CIHR Grant Milestone 3A Decreasing Sample Prep Time From Days to Less Than Eight Hours 12464 1Xceed Meets HTX CIHR Grant Milestone 3A Decreasing Sample Prep Time From Days to Less Than Eight Hours 12464 2
...ence Call to be Held at 9:00 a.m. Eastern Time Tod...United Therapeutics Corporation (Nasdaq: UTHR ) ...ug Administration (FDA) has approved ADCIRCA(TM) (... recommended dose of 40 mg, as the first once-dail...e treatment of pulmonary arterial hypertension (PA...
...LIS, Md., May 22 PharmAthene, Inc. (NYSE Amex: ...ountermeasures against biological and chemical thr...ed its comprehensive regulatory strategy to the U....e non-clinical and clinical development plans for ...inant protective antigen anthrax vaccine. , , The...
Other Medicine Technology:FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 2FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 3FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 4PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA 2PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA 3PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA 4
... Web-based and RFID-enabled location system that a...ow and utilization of resources throughout the per...gileTrac collects patient information including lo... might experience. This information is directed to...
RoamAlert Eco
awarix Enterprise Visibility Solutions for Healthcare
Radianse Indoor Positioning Patient Location
Medicine Products: